|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 47/26 | (2013.01) | ||
| A61K 9/51 | (2006.01) | ||
| A61K 9/19 | (2013.01) | ||
| A61K 9/51 | (2013.01) | ||
| A61K 9/5146 | (2013.01) | ||
| A61K 9/5153 | (2013.01) | ||
| A61K 9/5192 | (2013.01) |
| (11) | Number of the document | 3416624 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17754041.6 |
| Date of filing the European patent application | 2017-02-21 | |
| (97) | Date of publication of the European application | 2018-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/018743 |
| Date | 2017-02-21 |
| (87) | Number | WO 2017/143346 |
| Date | 2017-08-24 |
| (30) | Number | Date | Country code |
| 201662296840 P | 2016-02-18 | US |
| (72) |
GETTS, Daniel R. , US
FOKTA, Frank , US
PEARSON, Ryan , US
|
| (73) |
Cour Pharmaceuticals Development Company Inc. ,
8025 Lamon Ave, Skokie, IL 60077,
US
|
| (54) | PROCESS FOR THE PREPARATION OF TOLERIZING IMMUNE-MODULATING PARTICLES |
| PROCESS FOR THE PREPARATION OF TOLERIZING IMMUNE-MODULATING PARTICLES |